Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01253200 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of the Blazer® Open-Irrigated Catheter for Treatment of Type 1 Atrial Flutter
A NA study of Atrial Flutter, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- NA
- Development phase
- 302
- Enrollment target
- 20
- Study locations
NCT01253200 is a NA study of Atrial Flutter that has completed, run by Boston Scientific Corporation. The registered enrollment target is 302 participants, below the 2,110-participant average among 23 other Atrial Flutter trials with a reported enrollment target (86% lower). The trial reports 20 study locations across 14 states.
The verdict
NCT01253200, a NA study of Atrial Flutter, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 302 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of the BLOCk-CTI study is to evaluate the safety and effectiveness of the Blazer® Open-Irrigated Ablation Catheter for the treatment of sustained or recurrent type 1 atrial flutter. This study will compare outcomes in patients treated with the Blazer® Open-Irrigated Ablation Catheter to outcomes in patients treated with open-irrigated radiofrequency ablation catheters that have received FDA market approval for the treatment of type 1 atrial flutter.
Conditions Studied
Interventions
- DEVICE Blazer® Open-Irrigated Ablation Catheter
- DEVICE Control Catheter
Study Locations (20)
Ohio
- Cleveland Clinic Foundation - Cleveland
- Ohio State University Medical Center - Columbus
- Ohio Health Research Institute - Columbus
California
- St. Jude Medical Center - Fullerton
- Regional Cardiology Associates - Sacramento
Florida
- West Coast Arrhythmia Center - Hudson
- Tallahassee Memorial Hospital - Tallahassee
Georgia
- Emory University Hospital - Atlanta
- Georgia Health Sciences University - Augusta
Massachusetts
- Brigham and Women's Hospital - Boston
- Caritas St. Elizabeth's Medical Center - Boston
Alabama
- University of Alabama at Birmingham - Birmingham
Colorado
- Colorado Springs Cardiologist, P.C. - Colorado Springs
District of Columbia
- Washington Hospital Center - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 302 participants |
| Start Date | 2011-01 |
| Est. Completion | 2014-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01253200
The ClinicalTrials.gov registry entry for NCT01253200 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 302 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,110-participant average among 23 other Atrial Flutter trials with a reported enrollment target (86% lower). The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Atrial Flutter appearing as the primary indexed condition, and to 2 interventions - of which Blazer® Open-Irrigated Ablation Catheter is the first listed.
NCT01253200 reports 20 study locations spanning 14 distinct geographic areas - top geographies include Ohio, California, Florida.
Frequently Asked Questions
What is clinical trial NCT01253200 about?
NCT01253200 is a clinical study titled "Clinical Evaluation of the Blazer® Open-Irrigated Catheter for Treatment of Type 1 Atrial Flutter". The purpose of the BLOCk-CTI study is to evaluate the safety and effectiveness of the Blazer® Open-Irrigated Ablation Catheter for the treatment of sustained or recurrent type 1 atrial flutter. This study will compare outcomes in patients treated with the Blazer® Open-Irrigated Ablation Catheter to ...
What is the current status of trial NCT01253200?
This trial is currently completed. It is a NA study. The enrollment target is 302 participants. The study started on 2011-01. Estimated completion is 2014-01.
What conditions does trial NCT01253200 study?
This clinical trial studies the following conditions: Atrial Flutter.
What interventions are being tested in trial NCT01253200?
The interventions under investigation include: Blazer® Open-Irrigated Ablation Catheter (DEVICE), Control Catheter (DEVICE).
Who is sponsoring clinical trial NCT01253200?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01253200 being conducted?
This trial has 20 study locations across Alabama, California, Colorado, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Flutter
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
The Z Stitch Early Bed Rest Assessment Study
RECRUITING · NA
-
RESOLVE-AF: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy.
ACTIVE NOT RECRUITING · NA
-
Evaluation of the Use of Apple Watch Features for Identification of Cardiac Arrhythmias
COMPLETED · NA
-
Clinical Study to Evaluate the Catheter Robotics Amigo for Performing Right-Sided Electrophysiology Mapping Studies
COMPLETED · NA
-
iPhone Helping Evaluate Atrial Fibrillation Rhythm Through Technology
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.